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Site-speciﬁc conjugation of 8-ethynyl-BODIPY to
a protein by [2 + 3] cycloaddition†
Marcel Albrecht,a Andreas Lippach,a Matthias P. Exner,b Jihene Jerbi,c
Michael Springborg,c,d Nediljko Budisab and Gerhard Wenz*a
We report a straightforward synthesis of 8-ethynyl-BODIPY derivatives and their potential as ﬂuorescent
labeling compounds using an alkyne–azide click chemistry approach. The ethynyl substituted BODIPY
dyes at the meso-position were reacted under Cu+ catalysis and mild physiological conditions in organic
and biological model systems using benzyl azide and a Barstar protein which was selectively modiﬁed by
a single amino acid substituted methionine at the N-terminus (Met1) → azidohomoalanine (Aha). Conju-
gation with the protein and the model azide was indicated by a signiﬁcant blue shift upon formation of
the triazole moiety system, which allowed easy distinction between free and coupled dyes. This blue shift
was rationalized by the perpendicular orientation of the triazole relative to the chromophore using time
dependent density functional theory (TDDFT) calculations. A full spectroscopic and thermodynamic
characterization of the protein revealed that a ﬂuorophore was incorporated without the cross inﬂuence
of protein stability and functional integrity. Furthermore, model reactions of 8-ethynyl-BODIPY derivatives
with benzyl azide under copper-free conditions indicate second order kinetics with high rate constants
comparable with those found for the strain-promoted azide–alkyne cycloaddition (SPAAC). In this way,
we establish a unique and highly eﬃcient method to introduce alkyne-BODIPY into a protein scaﬀold
potentially useful for diverse applications in areas ranging from fundamental protein dynamics studies to
biotechnology or cell biology.
Introduction
The visualization of enzyme and protein mediated biochemical
processes is one of the most challenging tasks in the research
field of life sciences. The introduction of fluorophores into
proteins is the method of choice as it allows both in vitro and
in vivo real time imaging by commonly used spectroscopic
methods with relatively low costs and high selectivities. Funda-
mental strategies for the combination of fluorescent dyes with
proteins include self-labeling tags in which a specific peptide
sequence of the protein of interest (POI) is directly modified
by the labeling compound, self-labeling protein (SLP) in which
the fluorophore contains both the label and the functional
moiety that are able to react with the SLP, and enzyme-
mediated labeling of tags.1
A breakthrough in the detection of fluorophores in living
cells was achieved through the discovery of fluorescent pro-
teins (FPs) as highly selective and stable protein tags. In this
context, the green fluorescent protein (GFP) was the first
example which was introduced into the POI by using eﬃcient,
genetic approaches.2 During the last few decades, based on
their easy accessibility various fluorescent proteins with
tunable photochemical properties have been employed in cell
imaging techniques.3 However, both in in vivo and in vitro
experiments the FP approach often suﬀers from dramatic
drawbacks caused by the relatively large size of the used FPs
resulting in a limitation on potential applications. To over-
come size-induced side eﬀects, various synthetic methods for
the selective binding of chromophores to POIs such as modifi-
cations of cysteine containing peptides,4 metathesis reactions,5
palladium catalyzed cross-coupling reactions6 or azide/acetyl-
ene click-chemistry functionalizations7 have been established.
Based on these general considerations the site-directed and
residue-specific co-translational decoration of proteins with
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small, easily accessible fluorophores have recently become
widely used conjugation approaches in molecular and cellular
biology.8 The main motivation for these experiments is that
such modifications caused by addition of only a few atoms to
the amino acid side chain lower the risk of compromising
protein structural and functional integrity.9 Furthermore,
many organic dyes have better photophysical properties and
are usually more than 20 times smaller than the widely used
fusion-tagged auto-fluorescent proteins.10 For biological appli-
cations, such fluorescent dyes, however, need to be fully bio-
compatible and meet some specific requirements such as the
ability to pass through the plasma membrane and to avoid
nonspecific adsorption and cross-reactivity with cellular com-
ponents and structures. Furthermore, protein conjugation via
genetic code engineering is in general a two-step process
whereby a non-canonical amino acid (ncAA) with a chemically
distinct (in an ideal case bio-orthogonal) side chain should be
eﬃciently inserted into a target protein followed by specific
coupling of the fluorescent dye.11 In addition to genetic encod-
ing, the reactive side chain functionalities of the dye and ncAA
need to be orthogonal to each other (i.e., azides only reacting
with alkynes and vice versa). In particular, the copper catalyzed
[2 + 3] cycloaddition of azides and alkynes provides fundamen-
tal advantages compared to other synthetic techniques as it
allows a regioselective and economic combination of two reac-
tion partners with high conversion rates under mild reaction
conditions.12
In particular, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes
(BODIPYs) are suitable fluorescent dyes for the incorporation
into proteins as they are chemically stable compounds with
remarkable photophysical properties, such as high quantum
yields, sharp absorption and fluorescence peaks and relatively
large Stokes shifts.13 Based on these results a wide variety of
synthetic approaches of protein labelling with BODIPY deriva-
tives have been developed.14 Furthermore, several azide and
ethynyl substituted BODIPY derivatives have been applied in
copper catalyzed [2 + 3]-cycloadditions (the so-called click-
reaction) for the synthesis and modification of cell imag-
ing probes,15 fluorescent surfaces,16 sensor systems,17 or
nanoparticles.18
In the following we describe a new class of functional
BODIPYs, 8-ethynyl-BODIPYs, which show high reactivity
and a significant blue shift with regard to the click-reaction.
The general proof of principle of the site-specific conjuga-
tion of the ethynyl substituted BODIPYs with biologically
relevant systems was illustrated using a pseudo-wild type
barstar, a small ribonuclease inhibitor of 90 amino acids
that is widely used for folding studies, as a model protein
(Scheme 1).
Specifically, an engineered cysteine-free ‘pseudo-wild type’
barstar (ψ-b*), Pro28Ala/Cys41Ala/ Cys83Ala with only one Met
residue at the N-terminus (Met1) is used, making the incorpor-
ation of methionine analogs and subsequent coupling reaction
site-specific. Its N-terminal modification can generally be
expected to retain a functional protein structure while introdu-
cing novel functions.19
Results and discussion
Synthesis of 8-ethynyl BODIPY derivatives
TMS protected 8-ethynyl-BODIPYs 3/4 were synthesized
starting from 3-trimethylsilylpropynal, 2,4-dimethylpyrrole and
3-ethyl-2,4-dimethylpyrrole by the condensation reaction using
trifluoroacetic acid, subsequent oxidation with p-chloranil
and complexation with boron trifluoride diethyl etherate
(Scheme 2) as dark red solids in 17 (1) and 4% (2) yield,
respectively. Due to their instability under basic conditions,
Scheme 1 Bioorthogonal conjugation of 8-ethynyl-BODIPY 3 to
pseudo-wild type barstar with azidohomoalanine at position 1.
Scheme 2 Syntheses of 8-ethynyl-BODIPYs 3/4 and their conjugation
to benzyl azide.
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standard deprotection techniques using tetrabutylammonium
fluoride completely failed because complete decomposition
occurred. In contrast, the mild deprotection agent AgF furn-
ished the 8-ethynyl-BODIPYs 3/4 in yields of up to 56%. As an
alternative to the literature known synthesis of 3 through Stille
coupling of the corresponding 8-chloro BODIPY,20 we describe
a more straightforward synthetic strategy for 8-ethynyl
BODIPYs in only two steps from commercially available start-
ing materials.
Copper catalyzed model reactions
To get some primary information about their reactivities in
azide–alkyne cycloadditions, model reactions of BODIPYs 3/4
with benzyl azide were performed under copper catalyzed reac-
tion conditions. The progress of each reaction was analyzed
through both 1H NMR measurements of the crude reaction
mixture and through isolation of the reaction products 5/6. As
expected for copper catalyzed click-reactions only the for-
mation of the 1,4-triazole regioisomer indicated by one singlet
of the triazole moiety at 7.47 (5) and 7.45 ppm (6) was
observed. In general, due to the high aﬃnity of BODIPY deriva-
tives towards silica gel during the purification process signifi-
cantly lower yields of the isolated products were obtained as
determined by NMR. For example, the conjugate 5 was isolated
after a reaction time of 3 d at 50 °C in 38% yield while the
yield based on the NMR measurements was 52%.
Photophysical properties of BODIPY derivatives
The progress of the click-reaction of the BODIPY derivatives
was also observed through the changes within the absorption
and fluorescence spectra since the reactive ethynyl group is
conjugated with the BODIPY chromophore (Table 1 and
Fig. 1). In comparison with the 8-ethynyl-BODIPY 3, the 8-tri-
azolyl-BODIPY 5 showed hypsochromic shifts both in their
absorption and emission spectra which can be explained by
prevention of the conjugation between the triazole and the
BODIPY moiety in 5 due to steric hindrance of coplanar align-
ment of triazole and the BODIPY core. This is in contrast to
the literature known substituted BODIPYs in which an intro-
duction of a triazole moiety at the pyrrole positions induces a
red-shift in absorption and emission.13c Surprisingly, a similar
but weaker shift was also found for triazole derivative 6
bearing no bulky methyl groups at the 1- and 7-positions of
the BODIPY moiety. The quantum yields ϕ of compounds 3–6
are generally high which is typical for BODIPY derivatives.13
Interestingly, quantum yield of the methyl substituted BODIPY
5 is significantly lower than that of 6. This fact is in contrast to
the literature known observation in which an increased restric-
tion at the meso-position is connected with higher quantum
yields.21 We consider that twisted internal charge transfer
(TICT)22 between the BODIPY core and the triazole ring might
be responsible for this abnormal spectral characteristic.
Depending on the conformation of both parts of the molecule
the process might be aﬀected by the presence of the methyl
groups at the BODIPY moiety at 1- and 7-positions.
Computational analysis
The absorption and emission energies of the ethynyl- and tri-
azole-modified BODIPY derivatives in the ground state in the
ethanol environment were calculated using time dependent
DFT (TDDFT). The calculations were performed with the Gaus-
sian09 suite of programs.23 The molecular orbitals were visual-
ized using GaussView05. All geometries were optimized by the
B3LYP24,25 method with the standard 6-311G* basis set. We
optimized the structures of the energetically lowest singlet and
Table 1 Absorption maxima λabs, emission maxima λem and quantum
yields ϕ of the 8-ethynyl-BODIPY (3/4) and triazole BODIPY (5/6) deriva-
tives in ethanol solution, excitation at absorption maximum each
BODIPY derivatives λabs [nm] λem [nm] Stokes shift [nm] ϕ
3 540 550 10 0.61
4 540 551 11 0.64
5 506 522 16 0.18
6 520 540 20 0.75
Fig. 1 Absorption (a) and emission (b) spectra of 8-ethynyl-BODIPY
3 and the corresponding triazole substituted BODIPY 5 in ethanol
solution, excitations at 500 nm (3) and 481 nm (5), respectively.
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triplet states using the latter as an approximation to that of the
second-lowest singlet state.
While the ethynyl substituted BODIPYs 3 and 4 revealed
free rotation of the acetylene moiety, the triazole ring of
BODIPY 5 shows restricted rotation due to the interaction of
the heterocyclic ring with the methyl groups attached to the
BODIPY moiety at 1- and 7-positions. In the most stable con-
formation of 5, the triazole ring is oriented perpendicular to
the BODIPY unit, as shown in Fig. 2. As expected, in BODIPY
derivative 6, with lacking methyl groups at positions 1 and 7,
the triazole ring and the BODIPY unit adopt an energetically
favored conformation in which both rings are located in a
more planar structure with a relatively small torsion angle to
each other.
Subsequently, using TDDFT calculations we determine the
excitation spectra for BODIPYs 3/4 and 5/6 starting from the elec-
tronic ground state. Thereby the structure of the energetically
lowest triplet state is used as an approximation to that of the
first excited singlet state. Relevant data are specified in Table 2.
In general, the wavelengths of the calculated absorption
maxima were lower than the experimental data, but the calcu-
lated hypsochromic shifts from 482 to 458 nm (Δλ = 24 nm)
and 476 to 455 nm (Δλ = 21 nm) for the transformations of
BODIPYs 3 to 5 and 4 to 6, respectively, are in good agreement
with the experimental hypsochromic shifts of 34 nm (3 → 5)
and 20 nm (4 → 6). The high shift for the sterically hindered
methyl derivatives 3/5 can be explained through the disruption
between the frontier orbitals of the triazole and BODIPY moi-
eties in compound 5. Due to the reduced rotation barrier
between the triazole and BODIPY in the non-methylated com-
pound 6 the interconnection of the frontier orbitals is stronger
than that in 5 as shown in Fig. 2.
Copper-free cycloadditions
Surprisingly, the regioselective triazole formation was also
observed under copper free reaction conditions. As for the
copper catalyzed click-reaction of BODIPY 3 the sole formation
of the 1,4-regioisomer was evidenced by a single signal for the
triazole ring at 7.47 ppm. The reaction kinetics could be fol-
lowed through UV/vis measurements. A mixture of BODIPY 3
(25 μM), and benzyl azide (15 mM) in ethanol/water (2 : 1 v/v)
was incubated in a 10 mm quartz cuvette at 25 °C. The reaction
progress was visualized by a characteristic decrease in the
absorption maximum of the starting material 3 at 540 nm and
a simultaneous increase in the absorption band of product 5
at 506 nm (Fig. 3). Furthermore, the appearance of an isosbes-
tic point at 521 nm indicates the formation of one defined
species with high conversion rates without the formation of
any side products. Similar results were obtained for the
copper-free click reaction of BODIPY 4 to the corresponding
triazole substituted BODIPY 6.
The apparent pseudo first order rate constants were deter-
mined from the decay of the absorption at 540 nm of a 250 μM
solution of 3 with various concentrations of excess benzyl
Fig. 2 Calculated HOMOs (top) and LUMOs (bottom) of BODIPY
derivatives 5 (left) and 6 (right).
Table 2 Calculated and experimental absorption maxima of BODIPYs
3/4 and 5/6
Compound
Calc. λabs
[nm]
Exp. λabs
[nm]
3 482 540
4 476 540
5 458 506
6 455 520
Fig. 3 UV/vis spectra during the reaction of BODIPY 3 (25 μM) and
benzyl azide (15 mM) with BODIPY 5 under copper free reaction con-
ditions in water/ethanol (1 : 2 v/v).
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azide. Clear second order kinetics was found after plotting the
apparent rate constants as a function of the benzyl azide con-
centration. The obtained second order rate constant k2 3.56 ×
10−3 M−1 s−1 was even in the same order of magnitude like
those found for the strain-promoted azide–alkyne cyclo-
addition (SPAAC), which usually exhibit values between 3.0 ×
10−3 and 4 M−1 s−1.26 The observed extraordinary reactivity of
alkyne 3 may be rationalized by its conjugation with the elec-
tron deficient BODIPY core. In addition compared to the con-
version of 3 to triazole 5 a ten times smaller rate constant of
3.0 × 10−4 M−1 s−1 for the reaction of ethynyl BODIPY 4 with
benzyl azide was observed under copper-free coupling con-
ditions. The presence of an intensive peak at 509 nm in the
normalized absorption spectrum of 4 indicates an increased
aggregate formation of BODIPY 4 in aqueous ethanol solution
which inhibits the triazole formation (ESI Fig. S13†).
Conjugation with the protein
An azide-labeled protein Aha-ψ-b* was expressed in yields of
approximately 50% (5 mg L−1) compared to ψ-b* (10 mg
L−1).27 This is significantly better than yields of proteins con-
taining unnatural amino acids incorporated via suppression-
based methods, which typically do not exceed 20% of the wild-
type protein.28 Aha-ψ-b* was purified to >80% with single ion
exchange chromatography, as determined by SDS-PAGE, which
was suﬃcient for chemical modification. Conjugation of
alkyne-BODIPY 3 and Aha-ψ-b* occurred with 50% total yield
after desalting, during which the purity increased to >90% (see
Fig. 4A and B). Electrospray mass-spectrometric analysis
(ESI-MS) of Aha-ψ-b* clearly revealed a quantitative or near-
quantitative level of replacement without detectable amounts
of the parent protein as the contaminant (see Fig. 4C). While
the yield is suﬃcient for most experimental setups, it should
be noted that such conjugations usually exhibit eﬃciencies of
approx. 80% (see Li et al., 2010 29 for an example). However, as
there is no pronounced mass peak corresponding to the start-
ing material Aha-ψ-b*, it can be concluded that the low yield is
caused by denaturation of proteins and losses during desalt-
ing, and can potentially be increased by optimization of reac-
tion conditions.
It can be seen in Fig. 4D that the conjugate exhibits a
slightly decreased thermal stability (the melting point is
lowered by 7 °C). However, this eﬀect may be reduced by
optimization of expression and reaction conditions.
The expression of the corresponding protein samples was
induced with 0.5 mM of Aha and 1 mM of IPTG at OD600 = 0.7.
After 4 h at 30 °C, cells were harvested. A sample of uninduced
and induced culture (corresponding to OD600 = 1 in 1 mL) was
applied to a 17% SDS-PAGE gel to determine ψ-b* expression.
The induced culture shows a distinct band at the expected
migration length (M(Aha-ψ-b*) = 10 247.9 Da, indicated by the
arrow). Protein conjugation was analyzed through standard
expression techniques. The samples were run on a 17% tris-
glycine SDS-gel. Bands were visualized at 365 nm (Fig. 4B,
right) with Coomassie staining (Fig. 4B, left). Only the band
corresponding to BODIPY-Aha-ψ-b* exhibits fluorescence
without staining (Fig. 4B, right). Furthermore, success in
protein conjugation was controlled using ESI-MS measure-
ments of Aha-ψ-b* and BODIPY-Aha-ψ-b*. The mass spectrum
of Aha-ψ-b* shows a single peak at 10 246.8 Da (theoretical
mass 10 247.9 Da), the spectrum of BODIPY-Aha-ψ-b* exhibits
a pronounced peak at 10 518 Da (theoretical mass 10 520 Da).
To obtain further the same information about their thermal
stability samples of modified and unmodified proteins were
thermally denatured from 25 °C (Aha-ψ-b*) or 40 °C
(BODIPY-Aha-ψ-b*) to 95 °C. Circular dichroism was moni-
tored at 222 nm (characteristic minimum for α-helices). The
melting point only slightly dropped from 62.2 °C for Aha-ψ-b*
to 55.2 °C for BODIPY-Aha-ψ-b*.
From the UV/vis and fluorescence spectroscopy data shown
in Fig. 5 it can be concluded that conjugation with alkyne-
Fig. 4 SDS-PAGE gels of expression of Aha-ψ-b* (A), dito of ψ-b*, Aha-
ψ-b* and BODIPY-Aha-ψ-b* with and without Coomassie staining (B),
ESI-MS spectra (C) and thermal stability proﬁles (D) of Aha-ψ-b* and
BODIPY-Aha-ψ-b*, respectively.
Fig. 5 Absorption (A) and emission (B) spectra of coupling partners and
conjugates.
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BODIPY 3 endows Aha-ψ-b* with a distinct fluorescence that is
significantly blue-shifted compared to the unconjugated
BODIPY. These results are comparable with those found for
the model reactions (see Fig. 1).
As fluorescence tagging of proteins is very desirable, several
attempts have been made to modify amino acids that have
been installed via suppression techniques,30,31 or to directly
incorporate fluorescent amino acids.32 However, a full spectro-
scopic characterization of proteins with installed fluorophores
is rarely pursued, probably due to the low amounts of sub-
stances that can be typically obtained by stop-codon
suppression.
In the absorption spectra both BODIPY-Aha-ψ-b* and Aha-
ψ-b* show a peak at 280 nm, as expected for proteins (see
Fig. 5A). BODIPY-Aha-ψ-b*, however, shows an additional peak
at 508 nm, which is in correspondence with conjugated
BODIPY and clearly diﬀers from the spectrum of unconjugated
BODIPY 3, which shows a broad maximum between 540 and
570 nm. Similar results were observed in the corresponding
emission spectra of all coupling components. The fluorescence
was determined with an excitation wavelength of 500 nm. A
background spectrum of Tris buﬀer at pH 8 is also shown.
Aha-ψ-b* shows a minimal emission signal due to light scatter-
ing. BODIPY-Aha-ψ-b* exhibits a maximum at the expected
wavelength (522 nm) that is blue-shifted from the emission of
unconjugated BODIPY 3 at 550 nm.
Self-aggregation of BODIPY 3 was demonstrated by the
appearance of a UV/vis absorption band at 509 nm. With an
increasing content of an organic solvent this band decreased
and an increasing absorption of the free dye at 540 nm
appeared (ESI Fig. S12†). Significant amounts of the free dye
are necessary for the copper-free coupling reaction. The model
reactions already revealed that a content of 66 vol% of ethanol
in water is required for a suﬃcient coupling rate. On the other
hand this solvent is highly non-polar for the Barstar protein
leading to its denaturation. The copper-catalyzed click-reaction
was successful, because it is much faster and requires much
lower concentrations of the free dye than the copper-free coup-
ling. Currently we are looking for ethynyl-BODIPY derivatives
with improved solubility in water which would allow conju-
gation of proteins under copper-free physiological conditions.
Conclusion
8-Ethynyl-BODIPY 3 is a very promising new fluorescence label
which allows site-specific conjugation with and without
copper catalysis. The induced blue shift provides a simple test
for the success of the coupling which can be monitored using
optical spectroscopy techniques. As an example for its poten-
tial as a fluorescent probe the protein Aha-ψ-b* was success-
fully conjugated with alkyne-BODIPY 3 via a co-translationally
introduced Aha. While only specific in the absence of methion-
ine codons other than the start codon, this constitutes a
general protein modification technique, as internal methio-
nines are rarely structurally or functionally relevant. Based on
these facts the designed BODIPYs 3/4 are promising labeling
components in various biological systems under copper free
conditions with direct control over the formation of the result-
ing bioconjugates.
Experimental
Synthesis of ethynyl-BODIPYs
A mixture of 3-trimethylsilylpropynal (1.76 mL, 12 mmol) and
2,4-dimethylpyrrole (2.47 mL, 24 mmol) dissolved in 50 mL
dry dichloromethane was treated with a catalytic amount
(3 drops) of trifluoroacetic acid. After stirring at RT for 18 h
p-chloranil (2.95 g, 12 mmol) was added and the resulting
mixture was stirred at RT for 4 h. Then triethylamine (6.1 mL,
44 mmol) was added and stirring was continued for an
additional 45 min. After addition of boron trifluoride diethyl
etherate (6.0 mL, 48 mmol) the mixture was stirred for 1 h.
The solvent was evaporated under reduced pressure and the
crude reaction product was dissolved in a mixture of water and
diethyl ether. The aqueous phase was separated and extracted
with diethyl ether (2×). The combined organic fractions were
dried over magnesium sulfate and purified by column chrom-
atography (SiO2, n-hexane/dichloromethane 1 : 1), trimethyl-
silyl-ethynyl-BODIPY 1: a dark red solid (702 mg, 17%),
1H NMR (CDCl3): δ = 6.07 (s, 2H, pyrrole-H), 2.53 (s, 6H, methyl-
H), 2.45 (s, 6H, methyl-H), 0.30 (s, 9H, TMS-H) ppm. HRMS:
calc. for C16H19N2BF2Si: 316.1379; found: 316.1385.
2 was synthesized according to the procedure for the prepa-
ration of 1 using 2-methylpyrrole as the starting material: tri-
methylsilyl-ethynyl-BODIPY 2: a dark red solid (151 mg, 4%),
1H NMR (CDCl3): δ = 7.13 (d, J = 4.1 Hz, 2H, pyrrole-H), 6.25
(d, J = 4.1 Hz, 2H, pyrrole-H), 2.60 (s, 6H, methyl-H), 0.31 (s,
9H, TMS-H) ppm. 13C NMR (CDCl3): δ = 157.9, 150.6, 136.5,
128.6, 119.3, 109.1, 97.8, 14.9, −0.5 ppm. HRMS: calc. for
C18H23N2BF2Si: 344.1692; found: 344.1689.
3: A mixture of trimethylsilyl-ethynyl-BODIPY 1 (172 mg,
0.5 mmol) and silver(I) fluoride (96 mg, 0.75 mmol) dissolved
in 5 mL dry methanol was stirred under exclusion of light at
RT for 24 h. After the addition of hydrochloric acid (1 M,
2.25 mL, 2.25 mmol) and stirring for an additional 10 min the
mixture was filtered. Water was added and the mixture was
extracted with ethyl acetate (3×). The organic phase was
washed with a saturated sodium chloride solution and dried
over magnesium sulfate. The solvent was evaporated under
reduced pressure and the crude product was purified by
column chromatography (SiO2, n-hexane/ethyl acetate 10 : 1),
ethynyl-BODIPY 3: a red solid (93 mg, 54%), 1H NMR (CDCl3):
δ = 6.08 (s, 2H, pyrrole-H), 3.92 (s, 1H, CuCH), 2.54 (s, 6H,
methyl-H), 2.46 (s, 6H, methyl-H) ppm. 13C NMR (CDCl3): δ =
155.1, 142.6, 133.3, 121.0, 110.0, 94.4, 79.2, 15.4, 14.6 ppm.
IR (ATR): 3265, 2922, 2108, 1540, 1466, 1404, 1306, 1192, 1048,
976, 801, 704 cm−1. HRMS: calc. for C15H15N2BF2: 272.1296;
found: 272.1286.
4: A mixture of trimethylsilyl-ethynyl-BODIPY 2 (385 mg,
1.22 mmol) and silver(I) fluoride (232 mg, 1.83 mmol)
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dissolved in 10 mL dry methanol was stirred under exclusion
of light at RT for 24 h. After the addition of hydrochloric acid
(1 M, 5.50 mL, 5.50 mmol) and stirring for an additional 10 min
the mixture was filtered. Water was added and the mixture was
extracted with ethyl acetate (3×). The organic phase was
washed with a saturated sodium chloride solution and dried
over magnesium sulfate. The solvent was evaporated under
reduced pressure and the crude product was purified by
column chromatography (SiO2, dichloromethane), ethynyl-
BODIPY 4: a red solid (167 mg, 56%), 1H NMR (CDCl3): δ =
7.15 (d, J = 4.1 Hz, 2H, pyrrole-H), 6.27 (d, J = 4.1 Hz, 2H,
pyrrole-H), 3.64 (s, 1H, CuCH), 2.61 (s, 6H, methyl-H) ppm.
13C NMR (CDCl3): δ = 158.5, 136.7, 128.8, 120.5, 119.7, 88.5,
77.0, 15.0 ppm. IR (ATR): 3253, 2106, 1560, 1429, 1342, 1265,
1223, 1198, 1073, 998, 934, 779, 716 cm−1. HRMS: calc. for
C13H11N2BF2: 244.0983; found: 244.0982.
Copper(I) catalyzed click-reaction
5/6: A mixture of the corresponding ethynyl-BODIPY
(0.145 mmol), benzyl azide (19 mg, 0.145 mmol), copper(II)
sulfate pentahydrate (4 mg, 0.015 mmol) and sodium ascor-
bate (9 mg, 0.045 mmol) in 10 mL dimethyl sulfoxide and
0.1 mL water was stirred at 50 °C for 3 d. Dichloromethane was
added and the organic phase was successively washed with a
saturated sodium chloride solution and water. The mixture
was dried over magnesium sulfate and the crude reaction
product was purified by column chromatography (SiO2,
n-hexane/ethyl acetate 4 : 1→ 2 : 1).
Triazole substituted BODIPY 5, a dark red solid (22 mg,
38%), 1H NMR (CDCl3): δ = 7.47 (s, 1H, triazole-H), 7.38 (m,
3H, phenyl-H), 7.32 (m, 2H, phenyl-H), 5.96 (s, 2H, pyrrole-H),
5.64 (s, 2H, benzyl-H), 2.53 (s, 6H, methyl-H), 1.39 (s, 6H,
methyl-H) ppm. 13C NMR (CDCl3): δ = 156.6, 142.7, 140.8,
134.5, 132.3, 129.2, 129.1, 128.0, 123.2, 121.4, 110.0, 54.6, 14.6,
14.2 ppm. IR (ATR): 2923, 1729, 1545, 1507, 1467, 1405, 1307,
1180, 1154, 1044, 971, 816, 711, 697 cm−1. HRMS: calc. for
C22H22N5BF2: 405.1936; found: 405.1942.
Triazole substituted BODIPY 6, a dark red solid (18 mg,
33%), 1H NMR (CDCl3): δ = 7.75 (s, 1H, triazole-H), 7.42 (m,
3H, phenyl-H), 7.35 (m, 2H, phenyl-H), 7.10 (d, J = 4.2 Hz, 2H,
pyrrole-H), 6.27 (d, J = 4.2 Hz, 2H, pyrrole-H), 5.64 (s, 2H,
benzyl-H), 2.63 (s, 6H, methyl-H) ppm. 13C NMR (CDCl3): δ =
158.2, 141.8, 133.9, 133.5, 129.9, 129.4, 129.2, 128.2, 125.7,
119.6, 110.0, 54.5, 15.0 ppm. IR (ATR): 2923, 1735, 1551, 1455,
1261, 1181, 1002, 860, 763, 709 cm−1. HRMS: calc. for
C20H18N5BF2: 377.1623; found: 377.1617.
Copper free click-reaction
5: A mixture of the corresponding ethynyl-BODIPY
(0.145 mmol) and benzyl azide (19 mg, 0.145 mmol) in 10 mL
dimethyl sulfoxide and 0.1 mL water was stirred at 50 °C for
3 d. Dichloromethane was added and the organic phase was
successively washed with a saturated sodium chloride solution
and water. The mixture was dried over magnesium sulfate and
the crude reaction product was purified by column chromato-
graphy (SiO2, n-hexane/ethyl acetate 4 : 1→ 2 : 1).
Triazole substituted BODIPY 5, a dark red solid (14 mg,
24%). The spectroscopic data are identical to those obtained
using the copper(I) catalyzed approach.
Triazole substituted BODIPY 6, a dark red solid (21 mg,
35%). The spectroscopic data are identical to those obtained
using the copper(I) catalyzed approach.
Expression and purification of ψ-b* and Aha-ψ-b*
The proteins ψ-b* and Aha-ψ-b* were modified as described in
the previously described protocol.33 Details are provided in the
ESI†.
Cycloaddition on a model protein
Copper-induced cycloaddition was carried out as follows: 0.2
µg µL−1 Aha-ψ-b* (or ψ-b* as a negative control), 0.02 µg µL−1
alkyne-BODIPY 3, 1 mM CuSO4, 2 mM TCEP and 2 mM BCA
were mixed in PBS at pH 8 (137 mM NaCl, 2.68 mM KCl,
4.3 mM Na2HPO4, 1.47 mM KH2PO4) in a total volume of 30
µL. A spatula tip of powdered copper was added. The reaction
mixture was incubated at 37 °C for 4 h with agitation. Several
reaction supernatants were combined and purified on a Zeba
Desalt Spin Column (Pierce Biotechnology, Rockford, USA)
equilibrated with 50 mM Tris-HCl at pH 8.
Analysis of protein–dye conjugates
MS analysis of full length proteins was performed on an
LTQ-FT Ultra mass spectrometer (Thermo Scientific) coupled
online to an Ultimate 3000 HPLC Instrument (Thermo Scienti-
fic). Desalting was carried out with MassPREP Online Desalt-
ing Cartridges (Waters). Briefly, proteins were loaded in 1%
formic acid and eluted in a 5 min gradient from 6 to 95%
acetonitrile, 1% formic acid. Spectra were acquired in full scan
mode with a resolution of 200 000 at m/z 400 and afterwards
deconvoluted with the software Promass (Thermo Scientific)
using basic deconvolution default settings.
The melting curves of Aha-ψ-b* before and after conju-
gation were measured at a concentration of 20 µM by monitor-
ing the changes in residual ellipticity (i.e. unfolding) at
220 nm. The protein solutions were heated from 25 °C or
40 °C to 95 °C with a rate of 30 °C h−1 in 110-QS Hellma
quartz cells with an optical path length of 0.1 cm. These
experiments were performed on a Jasco J-715 dichrograph
equipped with a Peltier-type FDCD and water bath attachment
(model PTC-423S/15 and F250).
Fluorescence spectra of samples were recorded on a LS 55
(PerkinElmer Life Sciences, Boston, USA) with an excitation/
emission slit of 5 nm. The concentrations of the samples were
0.2 µM for BODIPY-Aha-ψ-b* and Aha-ψ-b*, and 1 µM for
BODIPY. The proteins were excited at 500 nm and the fluo-
rescence was measured in the range of 510–700 nm at 20 °C.
At least three spectra were accumulated for each sample.
Absorption spectra of samples were recorded on a Lambda
35 (PerkinElmer Life Sciences, Boston, USA) UV/vis spectro-
photometer in the range of 250–700 nm at 20 °C.
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Analysis of the model reactions
All NMR spectra including 1H, 13C, H/H-COSY and C/H-COSY
were recorded at room temperature by using a Bruker 400 MHz
Ultrashield Plus BioSpin Spectrometer Magnet System (1H:
400 MHz, 13C: 100.6 MHz). The chemical shifts are given in
parts per million (ppm) in relation to the corresponding
solvent signal.
IR spectra of solid samples were recorded on a Bruker
Tensor 27 FT-IR-Spectrometer equipped with a Golden Gate
Diamond ATR accessory using the software OPUS by Bruker.
UV kinetics were performed using an Evolution 220 UV/vis
Spectrophotometer (Thermo Scientific), 1 mM quartz glass
cuvettes (Hellma 110-QS) and ultrapure solvents.
The fluorescence measurements and the determination of
the quantum yields were performed according to the literature
known procedures established by Jung et al., 2014.13c
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